BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
Laser capture microdissection
,
Cisplatin
,
rs2476601
,
BRCA1
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phosphoinositide 3- kinase
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Trachea
Tongue main corpus
Eosinophil of peripheral blood
Temporal lobe
Midbrain
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Multiple-resistant Staphylococcus aureus infection
Pyloric ulcer
Alpha-1-antitrypsin deficiency
Injury of external ear
Cryptococcosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
foretinib
P79 protein, human
Apitolisib
GSK-1059615
HG-14-10-04
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-365a-3p
SLC25A46
PCDH11X
CTSK
ITGA11
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Dicer1 knockout gene expression during Schwann cell development
Carotid arteries from atherogenic ApoE knockout mice with carotid artery injury
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for phosphoinositide 3- kinase
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Dia…
Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas
Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer…
Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patie…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ